Application of immunotherapy based on dendritic cells stimulated by tumor cell-derived exosomes in a syngeneic breast tumor mouse model
We here evaluated the therapeutic effect of tumor cell-derived exosomes (TEXs)-stimulated dendritic cells (DCs) in a syngeneic orthotopic breast tumor model. The DC line DC2.4 and breast cancer cell line E0771 originally isolated from C57BL/6 mice were used. E0771 cells stably expressing the exosoma...
Main Authors: | Yin Ji Piao, So-Hyun Yoon, Hoe Suk Kim, Woo Kyung Moon, Wonshik Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580821002302 |
Similar Items
-
A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
by: Tuxiong Huang, et al.
Published: (2020-07-01) -
Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets
by: Graziela Gorete Romagnoli, et al.
Published: (2015-01-01) -
Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy
by: Marzieh Naseri, et al.
Published: (2020-01-01) -
DC-Derived Exosomes for Cancer Immunotherapy
by: Yi Yao, et al.
Published: (2021-07-01) -
Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
by: Niken M. Mahaweni, et al.
Published: (2013-10-01)